A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery (the START Study)

Smith, Julian (Primary Chief Investigator (PCI))

Project: Research

Status	Finished
Effective start/end date	23/02/21 → 22/02/26

Keywords

phase 2 study
cardiac surgery
cardiac valve surgery
treatment efficacy

Clinical Trial Phase

Phase II

Effects of RBT-1 on preconditioning response biomarkers in patients undergoing coronary artery bypass graft or heart valve surgery: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
Lamy, A., Chertow, G., Jessen, M., Collar, A., Brown, C. D., Mack, C. A., Marzouk, M., Scavo, V., Washburn, T. B., Savage, D., Smith, J., Bennetts, J., Assi, R., Shults, C., Arghami, A., Butler, J., Devereaux, P. J., Zager, R., Wang, C. & Snapinn, S. & 5 others, Browne, A., Rodriguez, J., Ruiz, S., Singh, B. & on behalf of START Investigators, Feb 2024, In: eClinicalMedicine. 68, 11 p., 102364.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

7 Link opens in a new tab Citations (Scopus)